Dräger, S.; Ewoldt, T.M.J.; Abdulla, A.; Rietdijk, W.J.R.; Verkaik, N.; Ramakers, C.; de Jong, E.; Osthoff, M.; Koch, B.C.P.; Endeman, H., on behalf of the DOLPHIN Investigators.
Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial. Pharmaceutics 2024, 16, 270.
https://doi.org/10.3390/pharmaceutics16020270
AMA Style
Dräger S, Ewoldt TMJ, Abdulla A, Rietdijk WJR, Verkaik N, Ramakers C, de Jong E, Osthoff M, Koch BCP, Endeman H on behalf of the DOLPHIN Investigators.
Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial. Pharmaceutics. 2024; 16(2):270.
https://doi.org/10.3390/pharmaceutics16020270
Chicago/Turabian Style
Dräger, Sarah, Tim M. J. Ewoldt, Alan Abdulla, Wim J. R. Rietdijk, Nelianne Verkaik, Christian Ramakers, Evelien de Jong, Michael Osthoff, Birgit C. P. Koch, and Henrik Endeman on behalf of the DOLPHIN Investigators.
2024. "Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial" Pharmaceutics 16, no. 2: 270.
https://doi.org/10.3390/pharmaceutics16020270
APA Style
Dräger, S., Ewoldt, T. M. J., Abdulla, A., Rietdijk, W. J. R., Verkaik, N., Ramakers, C., de Jong, E., Osthoff, M., Koch, B. C. P., & Endeman, H., on behalf of the DOLPHIN Investigators.
(2024). Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial. Pharmaceutics, 16(2), 270.
https://doi.org/10.3390/pharmaceutics16020270